Literature DB >> 28725921

[Parkinson's disease in the elderly].

Rüdiger Lange1, Frank Erbguth2.   

Abstract

Due to the increasing life expectancy and a higher incidence in the elderly, the number of elderly patients with idiopathic Parkinson's disease will increase in the coming years. Since the burden of comorbidities is higher and medication side effects are more likely in the elderly, particularly in the light of frequently occurring polypharmacy, increased awareness and therapeutic knowledge is necessary. Besides the therapy of motor symptoms, non-motor symptoms, e. g. neuropsychiatric and autonomic disorders, also need to be addressed as they can also greatly impair the quality of life. In more advanced stages of the disease, non-pharmacological treatment, medical aids and caregiving become more important. A close integration in the social environment is of great importance for the implementation.

Entities:  

Keywords:  Aged; Levodopa; Mobility; Parkinson Disease; Polypharmacy

Mesh:

Substances:

Year:  2017        PMID: 28725921     DOI: 10.1007/s00391-017-1284-5

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  36 in total

1.  Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations.

Authors:  M Pierantozzi; A Pietroiusti; L Brusa; S Galati; A Stefani; G Lunardi; E Fedele; G Sancesario; G Bernardi; A Bergamaschi; A Magrini; P Stanzione; A Galante
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

Review 2.  The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis.

Authors:  Lauren Hirsch; Nathalie Jette; Alexandra Frolkis; Thomas Steeves; Tamara Pringsheim
Journal:  Neuroepidemiology       Date:  2016-04-23       Impact factor: 3.282

3.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

4.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

Review 5.  Gastrointestinal dysfunction in Parkinson's disease.

Authors:  Alfonso Fasano; Naomi P Visanji; Louis W C Liu; Antony E Lang; Ronald F Pfeiffer
Journal:  Lancet Neurol       Date:  2015-06       Impact factor: 44.182

6.  Projected numbers of people with movement disorders in the years 2030 and 2050.

Authors:  Jan-Philipp Bach; Uta Ziegler; Günther Deuschl; Richard Dodel; Gabriele Doblhammer-Reiter
Journal:  Mov Disord       Date:  2011-10       Impact factor: 10.338

7.  Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

Authors:  E R Dorsey; R Constantinescu; J P Thompson; K M Biglan; R G Holloway; K Kieburtz; F J Marshall; B M Ravina; G Schifitto; A Siderowf; C M Tanner
Journal:  Neurology       Date:  2006-11-02       Impact factor: 9.910

8.  Incidence and remaining lifetime risk of Parkinson disease in advanced age.

Authors:  Jane A Driver; Giancarlo Logroscino; J Michael Gaziano; Tobias Kurth
Journal:  Neurology       Date:  2009-02-03       Impact factor: 9.910

9.  The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years.

Authors:  Mariese A Hely; Wayne G J Reid; Michael A Adena; Glenda M Halliday; John G L Morris
Journal:  Mov Disord       Date:  2008-04-30       Impact factor: 10.338

10.  Co-morbidity burden in Parkinson's disease: Comparison with controls and its influence on prognosis.

Authors:  Angus D Macleod; Hannah Goddard; Carl E Counsell
Journal:  Parkinsonism Relat Disord       Date:  2016-05-14       Impact factor: 4.891

View more
  3 in total

Review 1.  Safety and Tolerability of Pharmacotherapies for Parkinson's Disease in Geriatric Patients.

Authors:  Martin Klietz; Stephan Greten; Florian Wegner; Günter U Höglinger
Journal:  Drugs Aging       Date:  2019-06       Impact factor: 3.923

2.  Drug safety profiles in geriatric patients with Parkinson's disease using the FORTA (Fit fOR The Aged) classification: results from a mono-centric retrospective analysis.

Authors:  S Greten; J I Müller-Funogea; O Krause; M Klietz; F Wegner; G U Höglinger; N Simon; U Junius-Walker; S Gerbel
Journal:  J Neural Transm (Vienna)       Date:  2020-12-01       Impact factor: 3.575

3.  Visual Perturbation Suggests Increased Effort to Maintain Balance in Early Stages of Parkinson's to be an Effect of Age Rather Than Disease.

Authors:  Justus Student; David Engel; Lars Timmermann; Frank Bremmer; Josefine Waldthaler
Journal:  Front Hum Neurosci       Date:  2022-03-02       Impact factor: 3.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.